For years, researchers have suspected that a hormone called relaxin could be an effective treatment for certain cardiovascular diseases. It helps counteract scarring (fibrosis), prevents veins and ...

RQM+ Launches SMART Solutions Life Cycle Partnership Model Helps MedTech Companies Navigate MDR, IVDR, and AI-Enabled Device Development RQM+ says its SMART Solutions model integrates regulatory, ...

Researchers developed a high-sensitivity proteomics method to analyze individual human muscle fibers. The technique ...

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q4 2025 Earnings Call Transcript March 12, 2026 Corvus Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.15451 EPS, expectations ...

Dr Priyanka Dey has secured funding to develop a new technique that will give us a richer understanding of what cancer cells are made of and how they change as disease progresses ...

The silent hero of every flight: the seat fabrics that regulate temperature, provide comfort, and often go unnoticed by passengers.

Announced data from cohort 4 of soquelitinib atopic dermatitis Phase 1 trial demonstrating positive safety and efficacy results, including in patients who have received prior systemic therapy Initiate ...

The new pathology laboratory is expected to open in 2027.

Multicancer assays leverage cfDNA methylation patterns to detect malignancy and infer tumor origin, with reported tissue-of-origin prediction approaching 87% accuracy in real-world experience. The 142 ...

A novel approach has identified drugs in current use that could be repurposed for treating alcohol use disorder (AUD). In 2023, 28 million US adults had experienced AUD in the past year. But only ...

Artificial intelligence may be transforming pharmaceutical research, but it will not compress drug development timelines as dramatically as many expect, according to Bill Anderson, chief executive of ...

Spring calving cows are entering one of the most critical periods of their year from a nutritional standpoint. How we handle ...